Proposed Collection; 60-Day Comment Request; Food and Drug Administration (FDA) and the National Cancer Institute (NCI) Health Communication Survey (FDA-NCI), 26439 [2014-10520]
Download as PDF
26439
Federal Register / Vol. 79, No. 89 / Thursday, May 8, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Type of respondent
Web-based Application Form ...........
Web-based Update Mailer ................
Genetics Professional ......................
Genetics Professional ......................
Dated: April 30, 2014.
Karla Bailey,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2014–10521 Filed 5–7–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Food and Drug
Administration (FDA) and the National
Cancer Institute (NCI) Health
Communication Survey (FDA–NCI)
In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Cancer Institute (NCI),
National Institutes of Health (NIH), will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited on one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
SUMMARY:
Number of
responses per
respondent
60
600
1
1
Average
burden per
response
(in hours)
Total annual
burden hours
30/60
15/60
30
150
Communication Survey (FDA–NCI),
0925–NEW, National Cancer Institute
(NCI), National Institutes of Health
(NIH).
Need and Use of Information
Collection: This partnership between
NCI and FDA will include assessing the
public’s knowledge of medical devices,
communications related to product
recalls, nutritional supplement labeling,
and topics to inform FDA’s regulatory
authority over tobacco, such as risk
perceptions about new tobacco
products, product pack color gradations,
perceptions of product harm, and
tobacco product claims and labels. This
NCI–FDA survey will couple
knowledge-related questions with
inquiries into the communication
channels through which understanding
is being obtained, and assessment of
FDA-regulated material. This survey
will extend the information collected
and priorities from the Health
Information National Trends Survey
(HINTS) which has been to provide a
comprehensive assessment of the
American public’s current access to, and
use of, information about cancer across
the cancer care continuum from cancer
prevention, early detection, diagnosis,
treatment, and survivorship.
OMB approval is requested for 1 year.
There are no costs to respondents other
than their time. The total estimated
annualized burden hours are 2,159.
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To Submit Comments and for Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project contact: Bradford W. Hesse,
Ph.D., Health Communication and
Informatics Research Branch, 9609
Medical Center Drive, MSC 9761, Room
3E610, Rockville, MD 20850 or call nontoll free number 240–276–6721 or Email
your request, including your address, to
hesseb@mail.nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Proposed Collection: Food and Drug
Administration (FDA) and the National
Cancer Institute (NCI) Health
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total annual
burden hour
Individuals ........................................................................................................
emcdonald on DSK67QTVN1PROD with NOTICES
Type of respondents
4,318
1
30/60
2,159
Dated: May 1, 2014.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2014–10520 Filed 5–7–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
VerDate Mar<15>2010
16:18 May 07, 2014
Jkt 232001
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
E:\FR\FM\08MYN1.SGM
08MYN1
Agencies
[Federal Register Volume 79, Number 89 (Thursday, May 8, 2014)]
[Notices]
[Page 26439]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-10520]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request; Food and Drug
Administration (FDA) and the National Cancer Institute (NCI) Health
Communication Survey (FDA-NCI)
SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for opportunity for public comment
on proposed data collection projects, the National Cancer Institute
(NCI), National Institutes of Health (NIH), will publish periodic
summaries of proposed projects to be submitted to the Office of
Management and Budget (OMB) for review and approval.
Written comments and/or suggestions from the public and affected
agencies are invited on one or more of the following points: (1)
Whether the proposed collection of information is necessary for the
proper performance of the function of the agency, including whether the
information will have practical utility; (2) The accuracy of the
agency's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) Ways to enhance the quality, utility, and clarity of the
information to be collected; and (4) Ways to minimize the burden of the
collection of information on those who are to respond, including the
use of appropriate automated, electronic, mechanical, or other
technological collection techniques or other forms of information
technology.
To Submit Comments and for Further Information: To obtain a copy of
the data collection plans and instruments, submit comments in writing,
or request more information on the proposed project contact: Bradford
W. Hesse, Ph.D., Health Communication and Informatics Research Branch,
9609 Medical Center Drive, MSC 9761, Room 3E610, Rockville, MD 20850 or
call non-toll free number 240-276-6721 or Email your request, including
your address, to hesseb@mail.nih.gov. Formal requests for additional
plans and instruments must be requested in writing.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Proposed Collection: Food and Drug Administration (FDA) and the
National Cancer Institute (NCI) Health Communication Survey (FDA-NCI),
0925-NEW, National Cancer Institute (NCI), National Institutes of
Health (NIH).
Need and Use of Information Collection: This partnership between
NCI and FDA will include assessing the public's knowledge of medical
devices, communications related to product recalls, nutritional
supplement labeling, and topics to inform FDA's regulatory authority
over tobacco, such as risk perceptions about new tobacco products,
product pack color gradations, perceptions of product harm, and tobacco
product claims and labels. This NCI-FDA survey will couple knowledge-
related questions with inquiries into the communication channels
through which understanding is being obtained, and assessment of FDA-
regulated material. This survey will extend the information collected
and priorities from the Health Information National Trends Survey
(HINTS) which has been to provide a comprehensive assessment of the
American public's current access to, and use of, information about
cancer across the cancer care continuum from cancer prevention, early
detection, diagnosis, treatment, and survivorship.
OMB approval is requested for 1 year. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 2,159.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Number of responses per per response Total annual
respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Individuals................................. 4,318 1 30/60 2,159
----------------------------------------------------------------------------------------------------------------
Dated: May 1, 2014.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2014-10520 Filed 5-7-14; 8:45 am]
BILLING CODE 4140-01-P